3-12-2021 SmallCapVoice Interview with Biotricity (OTC.QB: BTCY)

SmallCapVoice-BTCY

AUSTIN, Texas (March XX, 2021) — SmallCapVoice.com (“SCV”) announces the availability of a new interview with Dr. Waqaas Al-Siddiq, CEO of Biotricity Inc. (OTCQB: BTCY) (“the Company”), a modern medical technology company delivering disruptive solutions to the multi-billion-dollar cardiac monitoring and diagnostic market.

Biotricity’s flagship Bioflux® product is a wearable medical device that enables physicians to accurately monitor and diagnose cardiac patients in real-time for effective treatment and pain management. While this technology alone targets a massive demographic, the Company’s full pipeline of remote cardiac monitoring and diagnostic solutions provides access to a multi-billion-dollar market hungry for digital innovation.

Speaking with SCV’s Stuart Smith, Dr. Al-Siddiq describes how Biotricity builds and delivers its technology to benefit patients, care providers and the broader healthcare industry, while building long-term value for the Company.

Link to full disclosure about compensation paid to SmallCapVoice.com by companies featured on our website or in our e-mail communications.

Facebook
Google+
Twitter
LinkedIn
Scroll to Top